SAP:TSXSaputo Inc. Analysis
Data as of 2026-03-14 - not real-time
CA$42.48
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Saputo’s shares are trading just above the 20‑day SMA and comfortably above the 50‑day SMA, indicating a short‑term bullish bias despite a bearish MACD histogram and a recent dip in trading volume. The price sits near a key support level around $41.70 and below a clear resistance near $43.60, suggesting limited upside unless the stock can break the resistance zone. Volatility over the past month is moderate at roughly 22%, while the beta of the stock is low, reflecting limited sensitivity to broader market moves. The consumer‑defensive sector provides a cushion in uncertain markets, and the company continues to pay a 1.86% dividend with a 50% payout ratio, supporting income‑focused investors. However, revenue has contracted by about 2% year‑over‑year, margins remain thin, and the DCF‑derived fair value of roughly $30 is well below the current market price, flagging an overvaluation risk. Recent material news disclosed the sale of an 80% stake in the Argentine dairy division, generating net proceeds that could strengthen the balance sheet but also reduces exposure to a volatile market. The transaction is expected to improve cash generation while leaving a 20% minority interest for future upside. Forward earnings estimates suggest a healthier EPS trajectory, yet the modest growth profile aligns more with a value‑oriented play than a high‑growth story. Overall, the stock’s defensive positioning and dividend yield are attractive, but the price premium and muted growth temper enthusiasm.
Investors should watch for a decisive move above the $43.60 resistance and any further shifts in volume or MACD momentum. A sustained break could unlock the modest upside implied by analyst targets, while a failure to clear resistance may keep the stock constrained near its current range. The Argentine divestiture, combined with a stable dividend and low beta, supports a cautious but not overly defensive stance for medium‑term holders.
Investors should watch for a decisive move above the $43.60 resistance and any further shifts in volume or MACD momentum. A sustained break could unlock the modest upside implied by analyst targets, while a failure to clear resistance may keep the stock constrained near its current range. The Argentine divestiture, combined with a stable dividend and low beta, supports a cautious but not overly defensive stance for medium‑term holders.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and decreasing volume
- Proximity to near‑term support level
- Limited upside until resistance is broken
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Price above 20‑day SMA and bullish trend direction
- Attractive dividend yield with sustainable payout
- Forward earnings improvement and analyst price targets above current level
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Defensive consumer staples positioning
- Stable dividend providing income cushion
- Fundamental growth constraints and current price premium
Key Metrics & Analysis
Financial Health
Revenue Growth-2.10%
Profit Margin3.39%
P/E Ratio27.2
ROE9.41%
ROA5.11%
Debt/Equity52.51
P/B Ratio2.6
Op. Cash FlowCA$1.5B
Free Cash FlowCA$1.1B
Technical Analysis
TrendBullish
RSI50.7
SupportCA$41.71
ResistanceCA$43.60
MA 20CA$42.60
MA 50CA$41.93
MA 200CA$35.30
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueCA$30.05
Target PriceCA$44.64
Upside/Downside5.08%
GradeOvervalued
TypeValue
Dividend Yield1.86%
Risk Assessment
Beta0.32
Volatility22.15%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.